YOLFTbeta
30

Beijing Science Sun Pharmaceutical Co Ltd

300485 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

7.44CNY-0.26 (-3.38%)

Price History

Full chart

Market Stats

Previous Close7.70
Open7.70
Day Range7.43 – 7.70
52-Week Range7.77 – 13.75
Volume3.44M
Market Cap4.17B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.37
Dividend Yield0.35%
Beta0.23
50-Day Avg9.00
200-Day Avg10.14

About

Beijing Science Sun Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of injections in China. The company offers products for cardiovascular, cerebrovascular, immunomodulation, and nervous systems, and other drugs. It is also involved in raw materials, solid oral preparations, and health products; extraction of traditional Chinese medicine; manufacture of Chinese and Western medicine preparations; research, development, production, and sales of tablets, hard capsules, powders, granules, and active pharmaceutical ingredients; outward investment, technology introduction and exchange, international business development, livestock and poultry production, and research and development of bio-organic fertilizers and bio-feeds. In addition, the company is engaged venture capital; equity investment through private equity funds; technology development, transfer, and services for biological products, pharmaceuticals, diagnostic reagents, and medical devices; biotechnology information consulting; sales of immunoassay reagents and laboratory instruments; research, development and industrialization of human vaccines; investment management and consulting for non-securities businesses, as well as inspection and testing services, consulting services, and health food production. The company was founded in 1999 and is headquartered in Beijing, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Biao Ma
  • Employees489
  • HeadquartersNo.8, Xingsheng Street, Beijing, China, 100176, China
  • Websitehttps://www.ssyy.com.cn

Leadership

  • Mr. Biao MaChairman & GM · b. 1964
  • Ms. Dongna LiangFinancial Director · b. 1981
  • Mr. Shen YinfuMarketing Director · b. 1965
  • Ms. Li MaDeputy GM & Director · b. 1969
  • Mr. Shuangquan KongChief Engineer · b. 1974
  • Mr. Xue Feng WangDeputy GM, Secretary of the Board & Director · b. 1978

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue245.02M396.01M480.21M589.85M607.14M616.24M749.99M1.43B1.19B1.09B1.05B734.55M476.57M416.48M404.72M
Growth (%)-+61.62%+21.26%+22.83%+2.93%+1.50%+21.70%+90.37%-16.59%-8.12%-3.97%-30.10%-35.12%-12.61%-2.82%
Cost of Revenue124.53M147.76M189.52M225.03M238.27M203.29M175.97M195.96M176.79M178.28M182.12M171.61M140.94M143.23M141.19M
Gross Profit120.50M248.25M290.70M364.82M368.86M412.95M574.02M1.23B1.01B915.95M868.68M562.94M335.63M273.26M263.53M
Gross Margin49.18%62.69%60.53%61.85%60.75%67.01%76.54%86.28%85.15%83.71%82.67%76.64%70.43%65.61%65.11%
Operating Expense27.38M100.77M106.83M130.91M126.32M113.76M241.53M901.03M836.94M736.03M429.68M308.30M213.89M356.23M272.40M
Operating Income93.12M147.48M183.87M233.91M242.54M299.19M332.50M330.77M177.17M179.92M439.00M254.64M121.74M-82.97M-8.87M
Operating Margin38.00%37.24%38.29%39.66%39.95%48.55%44.33%23.17%14.88%16.44%41.78%34.67%25.54%-19.92%-2.19%
EBITDA92.74M154.43M191.43M253.03M265.94M320.09M350.73M354.51M198.73M216.54M494.96M302.04M170.61M-36.72M60.09M
EBITDA Margin37.85%39.00%39.86%42.90%43.80%51.94%46.76%24.83%16.69%19.79%47.10%41.12%35.80%-8.82%14.85%
Net Income84.66M132.57M160.79M202.57M209.27M258.41M281.60M283.11M148.64M154.90M402.27M204.73M102.92M-68.85M14.57M
Net Income Margin34.55%33.48%33.48%34.34%34.47%41.93%37.55%19.83%12.48%14.16%38.28%27.87%21.60%-16.53%3.60%
R&D-14.86M16.35M32.51M29.69M27.47M16.26M31.93M50.38M71.67M103.84M100.63M77.73M46.22M69.51M
R&D as % of Total Revenue-3.75%3.40%5.51%4.89%4.46%2.17%2.24%4.23%6.55%9.88%13.70%16.31%11.10%17.18%
Interest Expense477.83K139.70K47.40K24.90K4.87M32.65K1.11M112.34K140.63K293.22K255.19K34.00K55.26K16.75K454.54K
Interest Expense % of Total Revenue0.20%0.04%0.01%0.00%0.80%0.01%0.15%0.01%0.01%0.03%0.02%0.00%0.01%0.00%0.11%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets279.77M395.13M541.04M718.35M1.94B2.22B2.45B2.76B2.81B2.99B3.40B3.57B3.62B3.55B3.57B
Total Liabilities32.39M35.18M47.33M71.71M62.00M118.63M133.91M205.07M94.26M141.13M118.54M157.10M154.61M166.48M175.95M
Total Equity245.72M358.28M492.07M645.14M1.88B2.10B2.32B2.55B2.67B2.80B3.24B3.37B3.44B3.36B3.37B
Cash126.94M175.32M325.08M482.13M999.40M1.04B1.47B573.09M789.12M672.53M161.54M226.21M120.16M75.26M88.13M
Total Debt-------28.16M16.90M------
Net Debt-126.94M-175.32M-325.08M-482.13M-999.40M-1.04B-1.47B-544.93M-772.22M-672.53M-161.54M-226.21M-120.16M-75.26M-

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow77.06M151.93M196.82M214.23M169.36M212.89M108.21M146.52M172.52M263.73M183.30M110.43M21.21M135.97M27.08M
Investing Cash Flow-53.06M-80.76M-19.42M-7.05M-682.92M-129.95M387.46M-1.02B51.61M-347.39M-662.47M32.39M-86.26M-175.36M-
Financing Cash Flow63.16M-22.80M-27.64M-50.13M1.03B-43.20M-60.00M-23.44M-8.10M-31.64M-31.31M-80.16M-41.40M-5.89M-
Capital Expenditure27.29M80.76M19.42M9.05M31.65M147.00M141.25M198.00M111.42M117.84M45.91M43.28M52.91M101.13M100.28M
Free Cash Flow49.77M71.18M177.40M205.18M137.70M65.89M-33.04M-51.49M61.10M145.88M137.38M67.15M-31.70M34.85M-73.20M
Dividends Paid42.00M20.00M27.00M49.50M54.00M43.20M60.00M57.60M58.10M30.02M31.31M80.88M41.40M10.59M250.89K
FCF to OCF64.58%46.85%90.13%95.78%81.31%30.95%-30.53%-35.14%35.42%55.32%74.95%60.81%-149.46%25.63%-270.33%
Dividend Paid to FCF84.39%28.10%15.22%24.13%39.21%65.56%-181.59%-111.87%95.08%20.58%22.79%120.44%-130.58%30.38%-0.34%

Earnings

Report DateOct 23, 2015Feb 29, 2016Apr 26, 2016Aug 25, 2016Oct 27, 2016Mar 1, 2017Apr 25, 2017Aug 17, 2017Oct 25, 2017Mar 14, 2018Apr 27, 2018Aug 16, 2018Oct 29, 2018Mar 27, 2019Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 29, 2020Aug 28, 2020Oct 28, 2020Mar 30, 2021Apr 29, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Jan 26, 2024Apr 30, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Apr 30, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate--------------------------------------------
EPS Actual0.110.110.120.150.150.120.090.130.200.170.120.150.160.150.090.100.070.050.050.120.090.050.090.090.110.550.220.270.04-0.100.000.52-0.11-0.19-0.400.180.010.060.080.020.01-0.080.01-0.31
Surprise--------------------------------------------
TimingPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-market-------------------After-hoursAfter-hours---After-hours-----

Key Statistics & Ratios

Market Cap4.17B
Enterprise Value2.73B
Trailing P/E0.00
Forward P/E0.00
Price / Sales10.72
Price / Book1.30
EPS-0.37
Book Value6.67
Revenue (TTM)388.64M
Gross Profit (TTM)252.25M
EBITDA19.97M
Profit Margin-45.51%
Operating Margin-12.89%
Return on Equity-5.52%
Return on Assets-0.45%
Shares Outstanding481.67M
Shares Float210.95M
Beta0.23
Dividend Yield0.35%
Dividend Rate0.03
Payout Ratio0.00%

Dividends

20261×
0.03May 27, 2026
20241×
0.02May 29, 2024
20231×
0.09May 23, 2023
20221×
0.17May 31, 2022
20211×
0.07May 10, 2021
20201×
0.06May 26, 2020
20191×
0.12May 28, 2019
20181×
0.12Jun 29, 2018
20171×
0.13Jun 6, 2017
20161×
0.09Apr 26, 2016

Stock Splits

  • Jun 29, 20182:1
  • Apr 26, 201620:10